Stock Events

Stock Events

Senseonics 

$9.73
435
-$0.17-1.72% 08:27 Today

Statistics

Day High
10.08
Day Low
9.46
52W High
11.58
52W Low
4.79
Volume
750,472
Avg. Volume
738,780
Mkt Cap
523.45M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.71
-0.48
-0.25
-0.02
Expected EPS
-0.52
Actual EPS
N/A

Financials

-196.03%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
35.26MRevenue
-69.11MNet Income

Analyst Ratings

13.33Average Price Target
The highest estimate is 18.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SENS. It's not an investment recommendation.
Tesla
67
TSLA
Apple
66
AAPL
Palantir Technologies
60
PLTR
Amazon
57
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Dexcom
DXCM
Mkt Cap34.27B
Dexcom produces continuous glucose monitoring systems for diabetes management, directly competing with Senseonics' Eversense CGM system.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories offers the FreeStyle Libre, a flash glucose monitoring system, competing in the glucose monitoring space.
Tandem Diabetes Care
TNDM
Mkt Cap1.49B
Tandem Diabetes Care manufactures insulin pumps and integrated diabetes management systems, competing in the broader diabetes management market.
Insulet
PODD
Mkt Cap10.07B
Insulet Corporation develops the Omnipod, an insulin management system, which competes with diabetes management solutions like Senseonics'.
Medtronic
MDT
Mkt Cap116.77B
Medtronic offers the Guardian Sensor 3 CGM and insulin pumps, providing integrated diabetes management solutions.
Mirum Pharmaceuticals
MIRM
Mkt Cap5.94B
Mirum Pharmaceuticals, though more focused on liver diseases, has interests in metabolic disorders, potentially overlapping with diabetes management.
Novo Nordisk
NVO
Mkt Cap201.64B
Novo Nordisk specializes in diabetes care with insulin and GLP-1 receptor agonists, indirectly competing in diabetes management.
Sanofi
SNY
Mkt Cap107.39B
Sanofi produces insulin and other diabetes medications, competing in the broader market for diabetes management.
Merck
MRK
Mkt Cap366B
Merck & Co., with its diabetes medication portfolio, including Glucophage, competes in the pharmaceutical management of diabetes.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb, through its metabolic disorders treatment portfolio, indirectly competes in the diabetes management space.

About

Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
Show more...
CEO
Timothy T. Goodnow
Employees
130
Country
United States
ISIN
US81727U3032
WKN
000A41MRZ

Listings

MU
DE
6L60.MU
F
DE
6L60.F
MU
DE
6L6.MU
STU
DE
6L60.STU

0 Comments

Share your thoughts

FAQ

What is Senseonics stock price today?▼
The current price of SENS is $9.73 USD — it has decreased by -1.72% in the past 24 hours. Watch Senseonics stock price performance more closely on the chart.
What is Senseonics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Senseonics stocks are traded under the ticker SENS.
Is Senseonics stock price growing?▼
SENS stock has risen by +6.11% compared to the previous week, the month change is a +83.33% rise, over the last year Senseonics has showed a +10.49% increase.
What is Senseonics market cap?▼
Today Senseonics has the market capitalization of 523.45M
When is the next Senseonics earnings date?▼
Senseonics is going to release the next earnings report on November 10, 2026.
What were Senseonics earnings last quarter?▼
SENS earnings for the last quarter are -0.63 USD per share, whereas the estimation was -0.61 USD resulting in a -2.84% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Senseonics revenue for the last year?▼
Senseonics revenue for the last year amounts to 35.26M USD.
What is Senseonics net income for the last year?▼
SENS net income for the last year is -69.11M USD.
How many employees does Senseonics have?▼
As of September 04, 2026, the company has 130 employees.
In which sector is Senseonics located?▼
Senseonics operates in the Health & Wellness sector.
When did Senseonics complete a stock split?▼
The last stock split for Senseonics was on October 20, 2025 with a ratio of 1:20.
Where is Senseonics headquartered?▼
Senseonics is headquartered in GERMANTOWN, United States.